Ansell (ANN) H2 2025 earnings summary

Executive summary

• Delivered on all FY 2025 performance objectives, with adjusted EPS of $1.26 at the upper end of guidance.

• Achieved strong sales and margin growth, with 8% organic sales growth, 10% EBIT growth, and nearly 20% adjusted EPS growth year-over-year.

• Successful integration of the KBU acquisition, completed ahead of schedule and exceeding synergy targets.

• Accelerated Productivity Investment Program (APIP) delivered $47m in savings, with focus shifting to IT and ERP upgrades.

• Sustainability progress includes expanded net zero targets, validation by Science Based Targets initiative, and improved ESG rankings.

Financial highlights

• Sales reached $2,003.3m, up 23.7% year-over-year; organic sales up 7.7%, best rate in over a decade (excluding pandemic effects).

• Adjusted EBIT rose 44.3% to $282.1m; EBIT margin improved by 200bps to 14.1%.

• Adjusted EPS at $1.26 (US126.1¢), at the upper end of guidance.

• Dividend per share increased by 30.7% to US50.20¢, reflecting strong shareholder returns.

• Net debt to EBITDA reduced to 1.6x, with strong liquidity and balance sheet flexibility.

Outlook and guidance

• FY 2026 adjusted EPS guidance set at $1.33–$1.45, requiring continued earnings growth.

• Pricing actions to fully offset higher U.S. tariffs (~$80m annualized cost); further increases being implemented in H1 FY 2026.

• Continued sales growth expected, with solid healthcare demand and selective industrial growth.

• Capex planned at $60–70m, focused on automation and sustainability.

• On-market share buyback program up to $200 million to resume in FY 2026.